Related articles:
Anastrozole
Raloxifene
Estrogen receptor
Aromatase inhibitor
CYP3A4
Selective estrogen receptor modulator
Gynecomastia
AstraZeneca
CYP2D6
Antiandrogen
Fatty liver
Imperial Chemical Industries
Key terms:
tamoxifen
cancer
women
risk
effects
cell
treatment
bone
patients
trial
tissue
clinical
dna
treated
estrogen receptor
growth
showed
patent
protein
binding
antagonist
compound
prevents
expression
reduce
inhibitor
recurrence
approval
metabolized
compete
walpole
side effects
been shown
anastrozole
gynecomastia
women who
angiogenesis
used to treat
raloxifene
endometrial
metabolites
astrazeneca
uterine cancer
receptor antagonist
cancer patients
bipolar disorder
cancer recurrence
tamoxifen treatment
postmenopausal women
selective estrogen receptor
Search external links cited by footnotes on Wikipedia page Tamoxifen:
|
|